Subjects -> MEDICAL SCIENCES (Total: 8186 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (205 journals)
    - ANAESTHESIOLOGY (105 journals)
    - CARDIOVASCULAR DISEASES (334 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (19 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (227 journals)
    - DENTISTRY (266 journals)
    - DERMATOLOGY AND VENEREOLOGY (162 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (121 journals)
    - ENDOCRINOLOGY (149 journals)
    - FORENSIC SCIENCES (43 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (178 journals)
    - GERONTOLOGY AND GERIATRICS (125 journals)
    - HEMATOLOGY (160 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (178 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (90 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2230 journals)
    - NURSES AND NURSING (331 journals)
    - OBSTETRICS AND GYNECOLOGY (199 journals)
    - ONCOLOGY (355 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (135 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (150 journals)
    - OTORHINOLARYNGOLOGY (76 journals)
    - PATHOLOGY (96 journals)
    - PEDIATRICS (254 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (153 journals)
    - PSYCHIATRY AND NEUROLOGY (800 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (182 journals)
    - RESPIRATORY DISEASES (109 journals)
    - RHEUMATOLOGY (76 journals)
    - SPORTS MEDICINE (77 journals)
    - SURGERY (388 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (151 journals)

HEMATOLOGY (160 journals)                     

Showing 1 - 122 of 122 Journals sorted alphabetically
Acta Angiologica     Open Access   (Followers: 3)
Adipocyte     Open Access  
Advances in Hematology     Open Access   (Followers: 13)
Africa Sanguine     Full-text available via subscription  
American Journal of Hematology     Hybrid Journal   (Followers: 46)
Anemia     Open Access   (Followers: 6)
Annals of Hematology     Hybrid Journal   (Followers: 14)
Arteriosclerosis, Thrombosis and Vascular Biology     Full-text available via subscription   (Followers: 25)
Artery Research     Hybrid Journal   (Followers: 4)
Artificial Cells, Nanomedicine and Biotechnology     Hybrid Journal   (Followers: 3)
ASAIO Journal     Hybrid Journal   (Followers: 2)
Best Practice & Research Clinical Haematology     Hybrid Journal   (Followers: 5)
Blood     Hybrid Journal   (Followers: 296)
Blood Advances     Open Access   (Followers: 9)
Blood and Lymphatic Cancer : Targets and Therapy     Open Access   (Followers: 7)
Blood Cancer Journal     Open Access   (Followers: 21)
Blood Cells, Molecules, and Diseases     Hybrid Journal   (Followers: 5)
Blood Coagulation & Fibrinolysis     Hybrid Journal   (Followers: 27)
Blood Pressure     Open Access   (Followers: 1)
Blood Pressure Monitoring     Hybrid Journal   (Followers: 2)
Blood Reviews     Hybrid Journal   (Followers: 20)
BMJ Open Diabetes Research & Care     Open Access   (Followers: 23)
Bone Marrow Transplantation     Hybrid Journal   (Followers: 15)
British Journal of Haematology     Hybrid Journal   (Followers: 54)
Canadian Journal of Diabetes     Hybrid Journal   (Followers: 9)
Case Reports in Hematology     Open Access   (Followers: 10)
Clinical and Applied Thrombosis/Hemostasis     Open Access   (Followers: 28)
Clinical Diabetes     Full-text available via subscription   (Followers: 30)
Clinical Diabetes and Endocrinology     Open Access   (Followers: 14)
Clinical Lymphoma & Myeloma     Full-text available via subscription   (Followers: 2)
Conquest : The Official Journal of Diabetes Australia     Full-text available via subscription   (Followers: 1)
Current Angiogenesis     Hybrid Journal   (Followers: 1)
Current Diabetes Reports     Hybrid Journal   (Followers: 14)
Current Diabetes Reviews     Hybrid Journal   (Followers: 13)
Current Hematologic Malignancy Reports     Hybrid Journal   (Followers: 2)
Current Opinion in Hematology     Hybrid Journal   (Followers: 14)
Cytotherapy     Full-text available via subscription   (Followers: 1)
Der Diabetologe     Hybrid Journal  
Diabetes     Full-text available via subscription   (Followers: 262)
Diabetes aktuell     Hybrid Journal   (Followers: 2)
Diabetes and Vascular Disease Research     Hybrid Journal   (Followers: 8)
Diabetes Care     Full-text available via subscription   (Followers: 285)
Diabetes Case Reports     Open Access  
Diabetes Educator     Hybrid Journal   (Followers: 10)
Diabetes Research and Clinical Practice     Hybrid Journal   (Followers: 18)
Diabetes Spectrum     Full-text available via subscription   (Followers: 14)
Diabetes Technology & Therapeutics     Hybrid Journal   (Followers: 8)
Diabetes Therapy     Open Access   (Followers: 13)
Diabetic Foot & Ankle     Open Access   (Followers: 9)
Diabetic Medicine     Hybrid Journal   (Followers: 93)
Diabetologia     Hybrid Journal   (Followers: 107)
Diabetologie und Stoffwechsel     Hybrid Journal  
Egyptian Journal of Hematology and Bone Marrow Transplantation     Open Access   (Followers: 9)
eJHaem     Open Access   (Followers: 1)
European Journal of Haematology     Hybrid Journal   (Followers: 12)
Experimental Hematology     Hybrid Journal   (Followers: 3)
Experimental Hematology & Oncology     Open Access   (Followers: 6)
Expert Review of Hematology     Hybrid Journal   (Followers: 4)
Fluids and Barriers of the CNS     Open Access   (Followers: 1)
Haematologica - the Hematology journal     Open Access   (Followers: 35)
Haemophilia     Hybrid Journal   (Followers: 15)
Hematologia     Full-text available via subscription   (Followers: 3)
Hematology     Open Access   (Followers: 9)
Hematology, Transfusion and Cell Therapy     Open Access   (Followers: 2)
Hemodialysis International     Hybrid Journal   (Followers: 3)
Hepatitis Monthly     Open Access   (Followers: 3)
Immunohematology : Journal of Blood Group Serology and Molecular Genetics     Hybrid Journal   (Followers: 3)
Indian Journal of Hematology and Blood Transfusion     Hybrid Journal   (Followers: 1)
Info Diabetologie     Full-text available via subscription  
InFo Hämatologie + Onkologie : Interdisziplinäre Fortbildung von Ärzten für Ärzte     Full-text available via subscription  
Integrated Blood Pressure Control     Open Access   (Followers: 1)
International Blood Research & Reviews     Open Access  
International Journal of Clinical Transfusion Medicine     Open Access   (Followers: 3)
International Journal of Diabetes in Developing Countries     Hybrid Journal   (Followers: 5)
International Journal of Diabetes Research     Open Access   (Followers: 6)
International Journal of Hematology     Hybrid Journal   (Followers: 3)
International Journal of Hematology Research     Open Access   (Followers: 2)
International Journal of Laboratory Hematology     Hybrid Journal   (Followers: 24)
JMIR Diabetes     Open Access  
Journal of Blood Medicine     Open Access  
Journal of Cerebral Blood Flow & Metabolism     Hybrid Journal   (Followers: 3)
Journal of Diabetes     Open Access   (Followers: 12)
Journal of Diabetes and its Complications     Hybrid Journal   (Followers: 13)
Journal of Diabetes and Metabolic Disorders     Open Access   (Followers: 6)
Journal of Diabetes Investigation     Open Access   (Followers: 6)
Journal of Diabetes Mellitus     Open Access   (Followers: 4)
Journal of Hematological Malignancies     Open Access  
Journal of Hematology and Transfusion Medicine     Open Access   (Followers: 1)
Journal of Hematopathology     Hybrid Journal   (Followers: 3)
Journal of Pediatric Hematology/Oncology     Hybrid Journal   (Followers: 6)
Journal of Social Health and Diabetes     Open Access  
Journal of Thrombosis and Haemostasis     Hybrid Journal   (Followers: 52)
Journal of Thrombosis and Thrombolysis     Hybrid Journal   (Followers: 30)
Leukemia     Hybrid Journal   (Followers: 23)
Leukemia and Lymphoma     Hybrid Journal   (Followers: 13)
Leukemia Research     Hybrid Journal   (Followers: 9)
Leukemia Research Reports     Open Access   (Followers: 1)
Leukemia Supplements     Full-text available via subscription  
Nederlands Tijdschrift voor Diabetologie     Hybrid Journal  
Nutrition & Diabetes     Open Access   (Followers: 18)
Oncohematology     Open Access   (Followers: 1)
Open Diabetes Journal     Open Access  
Open Hematology Journal     Open Access   (Followers: 1)
Open Hypertension Journal     Open Access  
Open Journal of Blood Diseases     Open Access  
Pediatric Blood & Cancer     Hybrid Journal   (Followers: 6)
Pediatric Hematology Oncology Journal     Open Access   (Followers: 3)
Peritoneal Dialysis International     Hybrid Journal  
Plasmatology     Open Access   (Followers: 1)
Platelets     Hybrid Journal   (Followers: 2)
Practical Diabetes     Hybrid Journal   (Followers: 4)
Primary Care Diabetes     Hybrid Journal   (Followers: 16)
Research and Practice in Thrombosis and Haemostasis     Open Access   (Followers: 2)
Revista Cubana de Hematología, Inmunología y Hemoterapia     Open Access  
Seminars in Hematology     Hybrid Journal   (Followers: 9)
Seminars in Thrombosis and Hemostasis     Hybrid Journal   (Followers: 28)
The Lancet Haematology     Full-text available via subscription   (Followers: 43)
Therapeutic Advances in Hematology     Hybrid Journal  
Thrombosis & Haemostasis     Hybrid Journal   (Followers: 105)
Thrombosis Research     Hybrid Journal   (Followers: 30)
Transplantation and Cellular Therapy     Hybrid Journal   (Followers: 11)
Veins and Lymphatics     Open Access   (Followers: 1)

           

Similar Journals
Journal Cover
Leukemia and Lymphoma
Journal Prestige (SJR): 0.976
Citation Impact (citeScore): 1
Number of Followers: 13  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1042-8194 - ISSN (Online) 1029-2403
Published by Taylor and Francis Homepage  [2652 journals]
  • CD36: a promising therapeutic target in hematologic tumors

    • Free pre-print version: Loading...

      Authors: Ningning Yue Qiqi Jin Cuicui Li Litian Zhang Jiajia Cao Chongyang Wu Department of Hematology; Lanzhou University Second Hospital, Lanzhou, China
      Pages: 1 - 17
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-10T05:09:22Z
      DOI: 10.1080/10428194.2024.2376178
       
  • Development and testing of a lymphoma clinical trial-specific frailty
           index: a secondary analysis of the NCIC-CTG LY.12 clinical trial

    • Free pre-print version: Loading...

      Authors: Abi Vijenthira Xinzhi Li Michael Crump Annette E. Hay Lois Shepherd Ralph M. Meyer Marina Djurfeldt Bingshu E. Chen Anca Prica a Division of Medical Oncology; Cancer Centre, Queen’s University, Hamilton, Canada
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-10T05:00:58Z
      DOI: 10.1080/10428194.2024.2370437
       
  • Elicitation of societal preferences for chronic lymphocytic leukemia’s
           treatments: a discrete choice experiment

    • Free pre-print version: Loading...

      Authors: Ludovica Borsoi Francesco Costa Carlo Milano Gaia Segantin Paolo Ghia Patrizio Armeni a Centre for Research on Health; Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italyb Università Vita Salute San Raffaele, Milan, Italyc IRCCS Ospedale San Raffaele, Milan, Italy
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-09T12:57:55Z
      DOI: 10.1080/10428194.2024.2374041
       
  • Maintenance therapy for CTCL: importance for prevention of disease
           progression

    • Free pre-print version: Loading...

      Authors: Emily R. Gordon Megan H. Trager Bradley D. Kwinta Connor J. Stonesifer Kaitlyn J. Lee Oluwaseyi Adeuyan Brigit A. Lapolla Oleg E. Akilov Paula A. Enz Emmanuella Guenova Pablo L. Ortiz-Romero Evangelia Papadavid Pietro Quaglino Sima Rozati Julia J. Scarisbrick Thomas Litman Larisa J. Geskin a Columbia University Vagelos College of Physicians; Microbiology, University of Copenhagen, Copenhagen, Denmark
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-08T02:14:26Z
      DOI: 10.1080/10428194.2024.2376164
       
  • Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL)
           post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic
           literature review and meta-analysis

    • Free pre-print version: Loading...

      Authors: James J. Wu Sally W. Wade Taha Itani Jean-Gabriel Castaigne Ioana Kloos Weimin Peng Steve Kanters Michael J. Zoratti Martin Dreyling Bijal Shah Michael Wang a Kite; A Gilead Company, Santa Monica, CA, USAb Wade Outcomes Research & Consulting, Salt Lake City, UT, USAc Kite, A Gilead Company, Munich, Germanyd Kite, A Gilead Company, Paris, Francee RainCity Analytics, Vancouver, Canadaf LMU University Hospital of Munich, Munich, Germanyg Moffitt Cancer Center, Tampa, FL, USAh The University of Texas MD Anderson Cancer Center, Houston, TX, USA
      Pages: 1 - 14
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-08T02:08:33Z
      DOI: 10.1080/10428194.2024.2369653
       
  • Anti-thymocyte globulin combined with post-transplantation
           cyclophosphamide reduce graft-versus-host disease in hematopoietic stem
           cell transplantation for pediatric leukemia

    • Free pre-print version: Loading...

      Authors: Mengze Hu Junhui Li Tao Hu Zhaoxia Zhang Shunqiao Feng Litian Xuan Rong Liu Department of Hematology; Children’s Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-07T07:20:30Z
      DOI: 10.1080/10428194.2024.2376179
       
  • Characteristics, treatment, and outcomes of mantle cell lymphoma with
           cutaneous involvement: a decade-long study at MD Anderson cancer center

    • Free pre-print version: Loading...

      Authors: Jared R. Zhang Susan Y. Wu Preetesh Jain Chi Young Ok Fangfang Yan Wendy Chen Onyeka Oriabure Bouthaina Dabaja Jillian Gunther Penny Fang Chelsea Pinnix Michael L. Wang Charles Gaulin a Department of Lymphoma/Myeloma; University of Texas MD Anderson Cancer Center, Houston, TX, USAb Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAc Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-07T07:18:30Z
      DOI: 10.1080/10428194.2024.2374457
       
  • Radiation therapy for the management of T cell cutaneous lymphomas.
           Updated results of the role of low dose total skin electron beam (TSEB)
           therapy

    • Free pre-print version: Loading...

      Authors: Ioannis Georgakopoulos Kalliopi Platoni Lia Papadavid Efrosini Kypraiou George Patatoukas Andromachi Kougioumtzopoulou Marios Koumourtzis Vassilis Kouloulias a 2nd Department of Radiology; Radiotherapy Unit, National Kapodistrian University of Athens School of Medicine, Athens, Greece
      Pages: 1 - 3
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-07T07:16:45Z
      DOI: 10.1080/10428194.2024.2374049
       
  • Idarubicin and cytarabine with and without midostaurin for FLT3-mutated
           acute myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Kendall Diebold Garrett Bourne Manuel Espinoza-Gutarra Zaid Al-Kadhimi Kimo Bachiashvili Sravanti Rangaraju Pankit Vachhani Ravi Bhatia Omer Jamy a Division of Hematology; Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAb Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
      Pages: 1 - 3
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-07T07:16:17Z
      DOI: 10.1080/10428194.2024.2373324
       
  • Importance of long-term follow-up of autologous stem cell transplantation
           for mantle cell lymphoma

    • Free pre-print version: Loading...

      Authors: Colin Stewart Carolyn Owen Neil Chua Anthea Peters Mona Shafey Alex Balogh Jeffrey Cao Douglas Stewart Robert Puckrin a Tom Baker Cancer Centre; University of Alberta, Edmonton, Canada
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-05T12:26:43Z
      DOI: 10.1080/10428194.2024.2373323
       
  • Can the radiation dose be safely reduced in the treatment of nk/T cell
           lymphoma'

    • Free pre-print version: Loading...

      Authors: Ximei Zhang Yanlan Chai Wei Lib; c, d Peiqi Zhao Huilai Zhang Peiguo Wang a Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, Chinab Key Laboratory of Cancer Immunology Biotherapy, Tianjin Cancer Institute, Tianjin, Chinac National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, Chinad Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
      Pages: 1 - 6
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-05T12:24:43Z
      DOI: 10.1080/10428194.2024.2370433
       
  • Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic
           myeloid leukemia patients: insights from real-world data in Brazil and the
           United States

    • Free pre-print version: Loading...

      Authors: Ana Carolina Mourão Toreli Marisol Miranda-Galvis Muhannad Sharara Marcelo Addas-Carvalho Eliana Miranda Leonardo Fechio Adriana Silva Santos Duarte Audrey Basso Gislaine Duarte Samuel Souza Medina Fernando Pericole Bruno Benites Kimya Jones Harmanpreet Singh Jaspreet Farmaha Ashutosh Vashisht Ravindra Kolhe Ashis K. Mondal Sara Teresinha Olalla Saad Carmino Antonio de Souza Jorge E. Cortes Katia Pagnano a Centro de Hematologia e Hemoterapia (Hemocentro-UNICAMP); Universidade Estadual de Campinas (UNICAMP), Campinas, Brazilb Georgia Cancer Center, Augusta University, Augusta, GA, USAc Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-05T01:32:58Z
      DOI: 10.1080/10428194.2024.2367057
       
  • Indolent B-cell non-Hodgkin lymphomas in children: high association with
           inborn errors of immunity

    • Free pre-print version: Loading...

      Authors: Nilgün Kurucu Tezer Kutluk Arzu Sağlam Deniz Cagdas Mithat Haliloğlu Bilge Volkan Salancı Burça Aydın Bilgehan Yalçın Ali Varan Ayşegül Üner a Department of Pediatric Oncology; Hacettepe University Faculty of Medicine Cancer Institute, Ankara, Turkeyb Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkeyc Department of Pediatric Immunology, Hacettepe University Faculty of Medicine, Ankara, Turkeyd Department of Pediatric Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkeye Faculty of Medicine, Department of Nuclear Medicine, Hacettepe University, Ankara, Turkey
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-05T01:29:17Z
      DOI: 10.1080/10428194.2024.2374031
       
  • Real-world treatment patterns and outcomes for patients with CLL using the
           Australian pharmaceutical benefits scheme (PBS) dataset

    • Free pre-print version: Loading...

      Authors: Constantine Tam Fei-Li Zhao Safee Azam Shu Chuen Li Boxiong Tang a The Alfred Hospital; Melbourne, Australiab Leukemia, Monash University, Clayton, Australiac BeiGene Proprietary Limited, Sydney, Australiad Prospection Proprietary Limited, Australiae University of Newcastle, Australiaf BeiGene USA, Incorporated, San Mateo, CA, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-05T01:26:53Z
      DOI: 10.1080/10428194.2024.2374040
       
  • It’s time to change the standard of care for hairy cell
           leukemia'!

    • Free pre-print version: Loading...

      Authors: Gal Lavie Tamar Tadmor a Hematology Unit; Bnai Zion Medical Center, Haifa, Israelb The Ruth Bruce Rappaport Faculty of Medicine, Haifa, Israel
      Pages: 1 - 3
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-05T01:24:40Z
      DOI: 10.1080/10428194.2024.2371497
       
  • Acute myeloid leukemia (AML) with chromosome 3 inversion: biology,
           management, and clinical outcome

    • Free pre-print version: Loading...

      Authors: Abdulrahman Alhajahjeh Jan Philipp Bewersdorf Rebecca P. Bystrom Amer M. Zeidan Shai Shimony Maximilian Stahl a Department Internal Medicine; King Hussein Cancer Center (KHCC), Amman, Jordanb School of Medicine, The University of Jordan, Amman, Jordanc Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USAd Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USAe Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAf National Heart, Lung, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-04T10:07:43Z
      DOI: 10.1080/10428194.2024.2367040
       
  • Safety and efficacy of acalabrutinib and obinutuzumab in treatment-naive
           chronic lymphocytic leukemia: a Japanese phase 1 study

    • Free pre-print version: Loading...

      Authors: Jun Takizawa Takanori Teshima Daisuke Ennishi Satoshi Ichikawa Ritsuro Suzuki Akira Kojima Yusuke Takahashi Nobuya Hayashi Hisashi Kawasumi Kosho Murayama Patricia Cheung Toshio Kawata Koji Izutsu a Department of Hematology; Endocrinology Oncology, Faculty of Medicine, Shimane University, Izumo, Japanf AstraZeneca K.K., Tokyo, Japang AstraZeneca K.K., Osaka, Japanh AstraZeneca, South San Francisco, CA, USAi Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-02T05:51:42Z
      DOI: 10.1080/10428194.2024.2370436
       
  • Bridging the gap: understanding contemporary autopsies in acute leukemia
           by comparing ante-mortem and post-mortem profiles

    • Free pre-print version: Loading...

      Authors: Deepthi Suresh Pulkit Rastogi Amanjit Bal Deepesh Lad Shano Naseem Arihant Jain Alka Rani Khadwal Pankaj Malhotra a Department of Pathology; Postgraduate Institute of Medical Education Research, Chandigarh, India
      Pages: 1 - 16
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-01T03:25:08Z
      DOI: 10.1080/10428194.2024.2372408
       
  • Cytomegalovirus infection risk with alemtuzumab therapy in hematological
           malignancies: a retrospective cohort study in the non-transplant setting

    • Free pre-print version: Loading...

      Authors: Joel George Lee Mozessohn Philip W. Lam a Department of Medicine; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canadab Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canadac Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-01T03:20:43Z
      DOI: 10.1080/10428194.2024.2371474
       
  • Haplo-cord transplant. Realizing the potential of umbilical cord blood
           grafts. – A review of techniques and analysis of outcomes

    • Free pre-print version: Loading...

      Authors: Koen van Besien Hongtao Liu Seunghee Margevicius Pingfu Fu Andrew Artz Ok-Kyong Chaekal Leland Metheny Tsiporah Shore Satyayit Kosuri Sebastian Mayer Alexandra Gomez-Arteaga Mi Kwon a Division of Hematology; Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USAe Servicio de Hematología Hospital General. Univ. Gregorio Marañon, Madrid, Spain
      Pages: 1 - 14
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-07-01T03:17:05Z
      DOI: 10.1080/10428194.2024.2361353
       
  • A temporal and multinational assessment of acute myeloid leukemia (AML)
           cancer incidence, survival, and disease burden

    • Free pre-print version: Loading...

      Authors: Laura J. Anderson Mariam Girguis Elise Kim Jitesh Shewale Megan Braunlin Winifred Werther Juliana E. Hidalgo-Lopez Faraz Zaman Christopher Kim a Center for Observational Research; Amgen, Thousand Oaks, CA, USAb Global Medical, Amgen, Thousand Oaks, CA, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-27T07:25:10Z
      DOI: 10.1080/10428194.2024.2360536
       
  • High red cell mass and high plasma volume are independently associated
           with thrombotic risk in polycythemia vera

    • Free pre-print version: Loading...

      Authors: Ivan Krecak Danijela Lekovic Andrija Bogdanovic Marko Lucijanic a Department of Internal Medicine; General Hospital of Sibenik-Knin County, Sibenik, Croatiab Faculty of Medicine, University of Rijeka, Rijeka, Croatiac University of Applied Sciences, Sibenik, Croatiad Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbiae Faculty of Medicine, University of Belgrade, Belgrade, Serbiaf Division of Hematology, University Hospital Dubrava, Zagreb, Croatiag School of Medicine, University of Zagreb, Zagreb, Croatia
      Pages: 1 - 5
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-20T10:47:24Z
      DOI: 10.1080/10428194.2024.2368639
       
  • Correction

    • Free pre-print version: Loading...

      Pages: 1 - 2
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-19T01:34:51Z
      DOI: 10.1080/10428194.2024.2357464
       
  • Therapy-related myeloid neoplasms with single-hit TP53 mutations share the
           clinical, molecular, and survival characteristics of their multi-hit
           counterparts

    • Free pre-print version: Loading...

      Authors: Taylor Zak Madina Sukhanova Juehua Gao Lucy Fu Yi-Hua Chen Qing Ching Chen Amir Behdad Hamza Tariq a Department of Pathology; Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USAb Department of Pathology Laboratory Medicine, Cleveland Clinic Florida, Weston, FL, USA
      Pages: 1 - 7
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-17T09:45:39Z
      DOI: 10.1080/10428194.2024.2367699
       
  • Experience of using venetoclax in relapsed T- cell lymphoma

    • Free pre-print version: Loading...

      Authors: Jasmine Zain Matthew Lunning Steven Rosen a Department of Hematology; City of Hope National Medical Center, Duarte, CA, USAb Department of Hematology, University of Nebraska Medical Center, Omaha, NE, USA
      Pages: 1 - 2
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-17T06:34:30Z
      DOI: 10.1080/10428194.2024.2363418
       
  • The multi-kinase inhibitor CG-806 exerts anti-cancer activity against
           acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinases

    • Free pre-print version: Loading...

      Authors: Guopan Yu Weiguo Zhang Mahesh Basyal Yuki Nishida Hideaki Mizumo Charlie Ly Hongying Zhang William G. Rice Michael Andreeff a Department of Leukemia; Section of Molecular Hematology Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USAb Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Chinac Aptose Biosciences, San Diego, CA, USA
      Pages: 1 - 16
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-14T01:48:44Z
      DOI: 10.1080/10428194.2024.2364839
       
  • Polycythemia vera: past, present and future

    • Free pre-print version: Loading...

      Authors: Ami B. Patel Lucia Masarova Ruben A. Mesa Gabriela Hobbs Naveen Pemmaraju a Division of Hematology; Harvard Medical School, Boston, MA, USA
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-14T01:44:22Z
      DOI: 10.1080/10428194.2024.2361836
       
  • Impact of chronic graft-versus-host disease on non-relapse mortality and
           survival

    • Free pre-print version: Loading...

      Authors: Justin Jiang Audrey M. Sigmund Qiuhong Zhao Patrick Elder Sumithira Vasu Samantha Jaglowski Alice Mims Hannah Choe Karilyn Larkin Sarah Wall Nicole Grieselhuber Basem William Sam Penza Don M. Benson Yvonne A. Efebera Nidhi Sharma a The Ohio State University College of Medicine; Columbus, OH, USAb Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USAc Division of Blood Cellular Therapy, OhioHealth, Columbus, OH, USA
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-12T03:13:54Z
      DOI: 10.1080/10428194.2024.2365910
       
  • Cardiovascular mortality among patients with diffuse large B-cell
           lymphoma: a population-based study

    • Free pre-print version: Loading...

      Authors: Danhua Hong Mengzhuo Yin Jie Li Zhiyong Deng Zhilei Ren Yun Zhou Shuijin Huang Xuejun Yan Weijie Zhong Feng Liu Chongzhe Yang a Department of Geriatrics; School of Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, Chinab School of Medicine, Institute of Clinical Medicine, Center for Medical Research on Innovation Translation, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, China
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-11T06:08:24Z
      DOI: 10.1080/10428194.2024.2364830
       
  • Cytarabine dose intensification improves survival in older patients with
           secondary/high-risk acute myeloid leukemia in matched real-world versus
           clinical trial data

    • Free pre-print version: Loading...

      Authors: Christoph Abé Jaana Keto Mathias Lilja Mie Konradsen Johan Mesterton Martin Höglund Vladimir Lazarevic Sören Lehmann Gunnar Juliusson a Quantify Research; Stockholm, Swedenb Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Swedenc Jazz Pharmaceuticals, Copenhagen, Denmarkd Quantify Research, Copenhagen, Denmarke Medical Management Centre, Karolinska Institutet, Stockholm, Swedenf Department of Medical Sciences, Uppsala University, Uppsala, Swedeng Department of Hematology, Oncology Radiation Physics, Skåne University Hospital, Lund University, Lund, Swedenh Department of Medicine, Karolinska Institute, Solna, Swedeni Department of Hematology, Academic Hospital, Uppsala, Sweden
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-11T04:22:13Z
      DOI: 10.1080/10428194.2024.2363430
       
  • Low-risk relapsed acute lymphoblastic leukemia in children and young
           adults: what have we learnt and what’s next'

    • Free pre-print version: Loading...

      Authors: Teena Bhatla Stacy Cooper Laura E. Hogan a Children’s Hospital of New Jersey at Newark Beth Israel; Newark, NJ, USAb Department of Oncology, Johns Hopkins University, Baltimore, MD, USAc Department of Pediatrics, Stony Brook Children’s, Stony Brook, NY, USA
      Pages: 1 - 7
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-11T04:20:13Z
      DOI: 10.1080/10428194.2024.2362408
       
  • Maintenance low-dose fixed duration lenalidomide and rituximab following
           bendamustine and rituximab induction in previously untreated chronic
           lymphocytic leukemia and small lymphocytic lymphoma

    • Free pre-print version: Loading...

      Authors: Julie E. Chang Tuo Wang KyungMann Kim Matthew Folstad Mariah Endres Mitch Howard Vaishalee Kenkre Christopher Fletcher Saurabh Rajguru a Department of Medicine; University of Wisconsin School of Medicine Clinics, Madison, WI, USA
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-10T12:00:17Z
      DOI: 10.1080/10428194.2024.2360535
       
  • TP53 Y220C mutations in patients with myeloid malignancies

    • Free pre-print version: Loading...

      Authors: Georgina Gener-Ricos Jan P. Bewersdorf Sanam Loghavi Alex Bataller Aaron D. Goldberg Christopher Famulare Koichi Takahashi Ghayas C. Issa Gautam Borthakur Tapan M. Kadia Nicholas J. Short Jayastu Senapati Bing Z. Carter Keyur P. Patel Hagop Kantarjian Michael Andreeff Eytan M. Stein Courtney D. DiNardo a Department of Leukemia; The University of Texas MD Anderson Cancer Center, Houston, TX, USAb Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAc Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
      Pages: 1 - 5
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-10T02:26:20Z
      DOI: 10.1080/10428194.2024.2363440
       
  • Successful treatment with belantamab mafodotin in a heavily pretreated
           patient with multiple myeloma and liver extramedullary disease

    • Free pre-print version: Loading...

      Authors: Nicola Sgherza Paola Curci Gabriella Di Carlo Domenica Grande Alessandro Capozzi Giuseppe Ingravallo Luca De Marco Paolo Ferreri Pellegrino Musto a Hematology; Radiation Oncology, Interdisciplinary Department of Medicine, “Aldo Moro” University School of Medicine, Bari, Italye Ophthalmology Unit, AOUC Policlinico, Bari, Italy
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-08T09:32:21Z
      DOI: 10.1080/10428194.2024.2364049
       
  • Advances in the treatment of adults with newly diagnosed B-cell acute
           lymphoblastic leukemia: the role of frontline immunotherapy-based regimens
           

    • Free pre-print version: Loading...

      Authors: Nicholas J. Short Hagop Kantarjian Elias Jabbour Department of Leukemia; The University of Texas MD Anderson Cancer Center, Houston, TX, USA
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-08T09:30:22Z
      DOI: 10.1080/10428194.2024.2364043
       
  • Fertility preservation in lymphoma patients treated with
           immunochemotherapy regimens with or without radiotherapy: results of a
           retrospective multicenter Italian study (Ferty care)

    • Free pre-print version: Loading...

      Authors: Ombretta Annibali Alessia Castellino Natalia Cenfra Mariavita Ciccarone Francesco Rotondo Carla Minoia Luigi Petrucci Guido Gini Chiara Rusconi Valentina Bozzoli Maura Nicolosi Gloria Margiotta Erika Meli Federica Cocito Sara Bigliardi Sabino Ciavarella Cristiano Tesei Francesco Zaja a Unit of Hematology; Stem cell Transplantation, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italyb Unit of Hematology, Santa Croce e Carle Hospital, Cuneo, Italyc Unit of Hematology, Santa Maria Goretti Hospital, Latina, Italyd Gemme Dormienti Onlus Association, Roma, Italye San Carlo di Nancy Hospital, Rome, Italyf Unit of Hematology, Rimini, Italyg IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italyh Policlinico Umberto I Hospital University Maggiore della Carità, Novara, Italym ASSt Grande Niguarda Hospital, Milano, Italyn Asst Monza Ospedale San Gerardo, Monza, Italyo UOSD di oncologia Area Sud sede di Sassuolo, AUSL Modena Osedale di Sassuolo, Modena, Italyp Department of Hematology, University of Rome Tor Vergata, Rome, Italyq DSM, University of Trieste, Trieste, Italy
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-07T12:57:13Z
      DOI: 10.1080/10428194.2024.2361358
       
  • A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects
           with resistant acute myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Kriti Gera Christina Cline Zeina Al-Mansour Andrew Medvec Ji-Hyun Lee Zhanna Galochkina Jack Hsu John Hiemenz Nosha Farhadfar Erin A. Dean John R. Wingard Randy Brown a Department of Medicine; University of Florida College of Medicine, Gainesville, FL, USAb Division of Hematology Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USAc University of Florida Health Cancer Center, Gainesville, FL, USAd Department of Biostatistics, University of Florida Health Cancer Center, Gainesville, FL, USAe Division of Quantitative Sciences, University of Florida Health Cancer Center, Gainesville, FL, USA
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-06T08:21:58Z
      DOI: 10.1080/10428194.2024.2361111
       
  • A phase II study of induction followed by intermittent duvelisib dosing in
           patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
           (CLL/SLL)

    • Free pre-print version: Loading...

      Authors: Geoffrey Shouse Lu Chen Tanya Siddiqi Alex Muir Jennifer R. Brown Stephen E. Spurgeon Alexey V. Danilov a City of Hope National Medical Center; CA, USAb Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAc The Knight Cancer Institute, Oregon Health Science University, Portland, OR, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-05T08:44:10Z
      DOI: 10.1080/10428194.2024.2361841
       
  • Tumor flare with T-cell-engaging bispecific antibodies

    • Free pre-print version: Loading...

      Authors: Carmelo Carlo-Stella Michael J. Dickinson Gloria Iacoboni Cecilia Carpio Natalie Dimier Martin Weisser Antonia Kwan Cristiano Ferlini a Department of Biochemical Sciences; Humanitas University, Rozzano, Milano, Italyb Department of Oncology Early Development, NY, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-05T08:42:13Z
      DOI: 10.1080/10428194.2024.2361100
       
  • Safety and efficacy of fedratinib in patients with myelofibrosis
           previously treated with ruxolitinib: primary analysis of FREEDOM trial

    • Free pre-print version: Loading...

      Authors: Vikas Gupta Abdulraheem Yacoub Ruben A. Mesa Claire N. Harrison Alessandro M. Vannucchi Jean-Jacques Kiladjian Hans-Joachim Deeg Salman Fazal Lynda Foltz Ryan J. Mattison Carole B. Miller Vinod Parameswaran Patrick Brown Christopher Hernandez Jia Wang Moshe Talpaz a Medical Oncology; Oncology, Avera Cancer Institute, Sioux Falls, SD, USAm Bristol Myers Squibb, Princeton, NJ, USAn Department of Hematology-Oncology, University of Michigan, Ann Arbor, MI, USA
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-05T05:35:19Z
      DOI: 10.1080/10428194.2024.2346733
       
  • Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients
           who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab:
           a target trial emulation

    • Free pre-print version: Loading...

      Authors: Marco Falcone Giusy Tiseo Gabriele Marchetti Jona Kalo Valentina Galfo Sara Occhineri Francesco Almerigogna Tommaso Matucci Niccolò Riccardi Lorenzo Roberto Suardi Ines Rina Ledja Sijoni Maria Costanza Caparello Raffaella Cassano Cassano Maria Livia Del Giudice Marinunzia Franciosa Flaminia Facella Gaspare Tancredi Rita Fazzi Sara Galimberti a Infectious Diseases Unit; Department of Clinical Surgery, University of Pisa, Pisa, Italy
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-04T12:03:27Z
      DOI: 10.1080/10428194.2024.2361099
       
  • Shift in first-line therapies for United States Veterans Affairs (VA)
           patients with chronic lymphocytic leukemia (CLL)

    • Free pre-print version: Loading...

      Authors: Christopher Raymond Frei Kellie Ryan Grace Oby Obodozie-Ofoegbu Amanda Marie Moore Chengwen Teng Kana Tai Lucero Laura Dean Davis Xavier Francisco Jones Zohra Nooruddin a College of Pharmacy; The University of Texas at Austin, San Antonio, TX, USAb Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USAc South Texas Veterans Health Care System, San Antonio, TX, USAd AstraZeneca US Medical Affairs, Gaithersburg, MD, USAe Department of Clinical Pharmacy Outcomes Sciences, College of Pharmacy, The University of South Carolina, Columbia, SC, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-04T12:02:58Z
      DOI: 10.1080/10428194.2024.2360526
       
  • Acute neurologic deterioration in a patient with asymptomatic
           Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin

    • Free pre-print version: Loading...

      Authors: Haridian de la Nuez Melián Hugo Luzardo Henríquez Alexia Suárez Cabrera Ruth Stuckey María Teresa Gómez-Casares a Hematology Department; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas, Spainb Department of Medical Sciences, University of Las Palmas de Gran Canaria, Las Palmas, Spain
      Pages: 1 - 3
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-03T02:33:39Z
      DOI: 10.1080/10428194.2024.2360520
       
  • Impact of gender representativeness in online symptom survey and clinical
           trial participation among patients with myeloproliferative neoplasms

    • Free pre-print version: Loading...

      Authors: Blake Langlais Amylou C. Dueck Heidi E. Kosiorek Carolyn Mead-Harvey Eric Meek Lauren Rogak John Mascarenhas Ruben Mesa Krisstina Gowin Jean Palmer Robyn Scherber Bridget Marcellino Ronald Hoffman Gina L. Mazza a Department of Quantitative Health Sciences; Mayo Clinic, Scottsdale, AZ, USAb Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USAc School of Medicine, Wake Forest University, Winston-Salem, NC, USAd Division of Hematology Oncology, University of Arizona, Tucson, AZ, USAe Division of Hematology Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-02T04:58:13Z
      DOI: 10.1080/10428194.2024.2356058
       
  • Novel chemotherapy combination of carfilzomib with dexamethasone,
           cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of
           relapsed/refractory aggressive plasma cell dyscrasias

    • Free pre-print version: Loading...

      Authors: Charlotte B. Wagner Kelley Julian Baylee Bryan Mary N. Steinbach Samuel Shewan Lindsay Maxwell Meghan Vigil Ghulam Rehman Mohyuddin Amandeep Godara Brian McClune Glicelda Galarza Fortuna Douglas Sborov a Department of Pharmacy; University of Utah Hospitals Clinics, Huntsman Cancer Institute, UT, USAb Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-06-02T04:11:51Z
      DOI: 10.1080/10428194.2024.2350670
       
  • MRD dynamics during maintenance therapy in 259 patients with nontransplant
           eligible multiple myeloma

    • Free pre-print version: Loading...

      Authors: Qian-qian Cui Zhi-hua Li Yan-ping Ma a Master’s Degree Student; Shanxi Medical University, Jinzhong, Chinab Sinopharm Tongmei General Hospital, Datong, Chinac Second Hospital of Shanxi Medical University, Taiyuan, China
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-30T01:51:34Z
      DOI: 10.1080/10428194.2024.2358857
       
  • Outcomes of patients aged ≥26 years with relapsed or refractory B-cell
           acute lymphoblastic leukemia in ZUMA-3 and historical trials

    • Free pre-print version: Loading...

      Authors: Monique C. MinnemaXiang YinRuthanna DaviSam KeepingJulie E. ParkTaha ItaniTsveta HadjivassilevaJean-Gabriel CastaigneRita Damico KhalidLang ZhouJames J. WuBijal D. Shaha University Medical Center Utrecht; Utrecht, Netherlandsb Medidata Solutions, New York, NY, USAc PRECISIONheor, Vancouver, Canadad Kite, a Gilead Company, Santa Monica, CA, USAe Moffitt Cancer Center, Tampa, FL, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-24T12:36:59Z
      DOI: 10.1080/10428194.2024.2353877
       
  • Acceleration of non-Hodgkin lymphoma progression during pregnancy in a
           murine model

    • Free pre-print version: Loading...

      Authors: Netanel A. HorowitzAli Abed Al WahadNoam P. BettmanShimrit Ringelstein-HarlevBenjamin BrennerTami Katza Department of Hematology; Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-23T08:49:39Z
      DOI: 10.1080/10428194.2024.2353879
       
  • Immune escape of B-cell lymphoblastic leukemic cells through a lineage
           switch to acute myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Karolina Bełdzińska-GądekEwa ZarzyckaKrzysztof PastuszakKatarzyna BormanKrzysztof LewandowskiJan M. ZauchaWitold Prejznera Department of Hematology; Medical University of Gdańsk, Gdansk, Polandg Laboratory of Hematology, Gdansk University Clinical Center, Gdansk, Poland
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-22T12:06:25Z
      DOI: 10.1080/10428194.2024.2351194
       
  • Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large
           B-cell lymphoma with mutated CD79B, high TCL1A expression, or
           over- expressed MYC/BCL-2

    • Free pre-print version: Loading...

      Authors: Yang LiuXiaopeng MaXikun WuXinfeng HouWei JinLina FuXiaolei XunYiling YuZhirong Shena BeiGene (Shanghai) Co; Ltd, Shanghai, Chinab BeiGene (Beijing) Co, Ltd, Beijing, China
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-22T11:26:53Z
      DOI: 10.1080/10428194.2024.2343779
       
  • VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic):
           clinical review in a rapidly emerging field

    • Free pre-print version: Loading...

      Authors: Luan PhanDanielle HammondNathaniel R. WilsonEmma M. GroarkeMrinal M. PatnaikNaveen Pemmarajua Department of Internal Medicine; The University of Texas McGovern Medical School, Houston, TX, USAb Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAc Hematology Branch, National Heart, Lung Blood Institute, National Institutes of Health, Bethesda, MD, USAd Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-21T12:09:58Z
      DOI: 10.1080/10428194.2024.2349950
       
  • Association of the pre-transplant CD4/CD8 ratio with the prognosis
           following allogeneic hematopoietic stem cell transplantation

    • Free pre-print version: Loading...

      Authors: Takashi NagayamaShin-ichiro FujiwaraRyutaro TominagaDaizo YokoyamaAtsuto NoguchiShuka FurukiTakashi OyamaShunsuke KoyamaRui MurahashiHirotomo NakashimaTakashi IkedaKazuki HyodoShin-ichiro KawaguchiYumiko TodaKento UminoDaisuke MinakataKaoru MoritaMasahiro AshizawaChihiro YamamotoKaoru HatanoKazuya SatoKen OhmineYoshinobu Kandaa Division of Hematology; Department of Medicine, Jichi Medical University, Tochigi, Japanb Division of Cell Transplantation Transfusion, Jichi Medical University Hospital, Tochigi, Japan
      Pages: 1 - 7
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-20T12:30:20Z
      DOI: 10.1080/10428194.2024.2352614
       
  • Octreotide as prophylaxis against asparaginase-associated pancreatitis: a
           case series study

    • Free pre-print version: Loading...

      Authors: Hiroshi HayashiYoshihiko MorikawaShogo AkahoshiKento IkegawaMotohiro MatsuiAtsushi MakimotoYuki Yuzaa Department of Hematology/Oncology; Tokyo Metropolitan Children’s Medical Center, Fuchu, Japanb Clinical Research Support Center, Tokyo Metropolitan Children’s Medical Center, Fuchu, Japan
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-20T12:14:40Z
      DOI: 10.1080/10428194.2024.2352085
       
  • Experience in improving treatment outcomes for childhood acute
           lymphoblastic leukemia: real-world results for a province in China,
           2011–2020

    • Free pre-print version: Loading...

      Authors: Yongzhi ZhengJiazheng LiHong WenKaizhi WengShuquan ZhuangXingguo WuJian LiHao ZhengXueling HuaZaisheng ChenJianda HuShaohua Lea Fujian Institute of Hematology; Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, Chinab Department of Pediatrics, The First Affiliated Hospital of Xiamen University, Xiamen, Chinac Department of Pediatric Hematology, Rheumatology Nephrology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Chinad Department of Pediatrics, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Chinae Department of Pediatrics, Nanping First Hospital of Fujian Province, Nanping, Chinaf Department of Hematology, Fujian Medical University 2nd Affiliated Hospital, Quanzhou, China
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-20T11:36:00Z
      DOI: 10.1080/10428194.2024.2350665
       
  • Successful pregnancy outcome in a patient with myelofibrosis receiving
           ruxolitinib treatment in the first trimester

    • Free pre-print version: Loading...

      Authors: Ivana UrosevicMarina DokicIvanka PercicAmir El FarraDunja BjelogrlicBorivoj Sekulica Clinical Center of Vojvodina; Clinic of Hematology, Novi Sad, Serbiab Medical Faculty, Department of Internal Medicine, University of Novi Sad, Novi Sad
      Pages: 1 - 3
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-20T08:24:40Z
      DOI: 10.1080/10428194.2024.2355558
       
  • Prevalence and clinicopathological features of incidentally detected
           TRBC1-dim populations in peripheral blood flow cytometry

    • Free pre-print version: Loading...

      Authors: Paul WadsworthJingjing ZhangTimothy MillerJoshua MenkeJean OakSebastian Fernandez-PolDepartment of Pathology; Stanford University School of Medicine, Stanford, CA, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-15T09:07:58Z
      DOI: 10.1080/10428194.2024.2354527
       
  • Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and
           follicular lymphoma disclose better outcomes for patients with lower
           exposure

    • Free pre-print version: Loading...

      Authors: Fabien DespasMaria ChaoukiSandra de BarrosBaptiste BonneauBen AllalJulie Guillermet-GuibertLoïc Ysebaerta Service de Pharmacologie Médicale et Clinique; Faculté de Médecine, Centre de Pharmacovigilance, de Pharmacoépidémiologie et d‘Informations sur le Médicament, CIC INSERM 1436, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, Toulouse, Franceb Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse, Institut National de la Santé et de la Recherche Médicale (Inserm) U1037, Centre National de la Recherche Scientifique (CNRS) U5071, Toulouse, Francec TouCAN (Laboratoire d‘Excellence Toulouse Cancer), Toulouse, Franced Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse (IUCT)-Oncopôle, Centre Hospitalier Universitare de Toulouse, Toulouse, Francee Service d‘Hématologie, Institut Universitaire du Cancer de Toulouse (IUCT)-Oncopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
      Pages: 1 - 3
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-15T09:05:47Z
      DOI: 10.1080/10428194.2024.2353330
       
  • Mitigating time toxicity in lymphoma and multiple myeloma

    • Free pre-print version: Loading...

      Authors: Mengyang DiChristopher T. SuAndrew J. CowanAjay K. GopalRahul Banerjeea Clinical Research Division; Fred Hutchinson Cancer Center, Seattle, WA, USAb Division of Hematology/Oncology, University of Washington, Seattle, WA, USAc Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, USA
      Pages: 1 - 12
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-15T08:54:07Z
      DOI: 10.1080/10428194.2024.2352086
       
  • Long-term results of the sequential combination of cladribine and
           rituximab in Hairy cell leukemia

    • Free pre-print version: Loading...

      Authors: Jennifer Marvin-PeekWei-Ying JenHagop M. KantarjianDavid McCueFadi G. HaddadWilliam WierdaAlessandra FerrajoliJan BurgerTareq AbusabJeffrey JorgensenSa A. WangKeyur PatelSanam LoghaviSusan O’BrienFarhad Ravandia Department of Leukemia; The University of Texas MD Anderson Cancer Center, Houston, TX, USAb Department of Hematology Oncology, Baylor College of Medicine, Houston, TX, USAc Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAd Department of Medicine, UCI Health Chao Family Comprehensive Cancer Center, Orange, CA, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-15T08:47:01Z
      DOI: 10.1080/10428194.2024.2349700
       
  • Correction

    • Free pre-print version: Loading...

      Pages: 1 - 1
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-15T06:43:07Z
      DOI: 10.1080/10428194.2024.2348945
       
  • Treatment of methotrexate-refractory primary central nervous system
           lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center

    • Free pre-print version: Loading...

      Authors: Seena CherianLisa ModelevskyAnne S. ReinerChristian Grommesa Department of Pharmacy; Memorial Sloan Kettering Cancer Center, New York, NY, USAb Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USAc Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-15T06:29:47Z
      DOI: 10.1080/10428194.2024.2343778
       
  • Emerging drug profile: JAK inhibitors

    • Free pre-print version: Loading...

      Authors: Alexander ColtoffAndrew Kuykendalla Hollings Cancer Center; Medical University of South Carolina, Charleston, SC, USAb Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA
      Pages: 1 - 12
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-13T05:53:28Z
      DOI: 10.1080/10428194.2024.2353434
       
  • A de novo germline RUNX1 variant preceding development of concurrent
           T-lymphoblastic leukemia and myelodysplastic syndrome

    • Free pre-print version: Loading...

      Authors: Cassandra P. WangJuanita E. FerreiraAlexander PlacekPaibel Aguayo-HiraldoGordana RacaBrent L. WoodKarin P. MillerThomas CoatesDavid R. FreyerAlexandra E. Kovacha Children’s Hospital Los Angeles; Cancer Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA
      Pages: 1 - 5
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-11T07:03:17Z
      DOI: 10.1080/10428194.2024.2347577
       
  • Safety and tolerability of AMG 330 in adults with relapsed/refractory AML:
           a phase 1a dose-escalation study

    • Free pre-print version: Loading...

      Authors: Farhad RavandiMarion SubkleweRoland B. WalterPankit VachhaniGert OssenkoppeleVeit BueckleinHartmut DöhnerMojca Jongen-LavrencicClaudia D. BaldusLars FranseckyTimothy S. PardeeHagop KantarjianPriscilla K. YenLata MukundanBharat PanwarMarc R. YagoSuresh AgarwalSophia K. KhaldoyanidiAnthony Steina Department of Leukemia; MD Anderson Cancer Center, Houston, TX, USAb Department of Medicine III, University Hospital, LMU Munich, Munich, Germanyc Laboratory for Translational Research, Gene Center, LMU Munich, Munich, Germanyd Translational Science Oncology, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USAk Amgen Inc, Thousand Oaks, CA, USAl Amgen Inc, South San Francisco, CA, USAm Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA, USA
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-07T10:13:45Z
      DOI: 10.1080/10428194.2024.2346755
       
  • Advances in the management of higher-risk myelodysplastic syndromes:
           future prospects

    • Free pre-print version: Loading...

      Authors: Georgina Gener-RicosJuan Jose Rodriguez-SevillaSamuel UrrutiaAlex BatallerAlexandre BazinetGuillermo Garcia-ManeroDepartment of Leukemia; The University of Texas MD Anderson Cancer Center, Houston, TX, USA
      Pages: 1 - 12
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-07T08:58:43Z
      DOI: 10.1080/10428194.2024.2344061
       
  • The degree of HLA matching determines the incidence of cytokine release
           syndrome and associated nonrelapse mortality in matched related and
           unrelated allogeneic stem cell transplantation with post-transplant
           cyclophosphamide

    • Free pre-print version: Loading...

      Authors: Peter A. von dem BorneBerit M. Kemps-MolsLiesbeth C. de WreedeAdriaan A. van BeekTjeerd J.F. SnijdersDaniëlle van LammerenJanneke TijmensenAniko Sijs-SzabóMirjam A. OudshoornConstantijn J.M HalkesPeter van BalenW.A. Erik MarijtJennifer M.L. TjonJoost S.P VermaatHendrik Veelkena Department of Hematology; Leiden University Medical Center, Leiden, the Netherlandsb Department of Immunology, Leiden University Medical Center, Leiden, the Netherlandsc Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlandsd Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlandse Department of Hematology, Haga ziekenhuis, Den Haag, The Netherlandsf Department of Hematology, Reinier de Graaf Gasthuis, Delft, the Netherlands
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-06T08:12:54Z
      DOI: 10.1080/10428194.2024.2344060
       
  • Risk factors for treatment-related bone loss and osteoporosis in patients
           with follicular lymphoma

    • Free pre-print version: Loading...

      Authors: Yong XingKaifeng YeChunyuan LiJinyao HeFei DongYun Tiana Department of Orthopedics; Peking University Third Hospital, Beijing, Chinab Department of Hematology, Peking University Third Hospital, Beijing, China
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-06T07:55:33Z
      DOI: 10.1080/10428194.2024.2348113
       
  • Real-world patterns and sequences of targeted therapy use in chronic
           lymphocytic leukemia and small lymphocytic lymphoma in the United States:
           a longitudinal study

    • Free pre-print version: Loading...

      Authors: Scott F. HuntingtonWendy Y. ChengEric M. SarpongSiyang LengMohammed Z. H. FarooquiUchechukwu Samuel AguMaryaline CatillonDominique LejeuneNathaniel DownesLisa MatayMei Sheng DuhEnrico De Nigrisa Yale School of Medicine, New Haven, CT, USAb Analysis Group, Inc, Boston, MA, USAc Merck & Co; Inc, Rahway, NJ, USAd University of Arizona, Tucson, AZ, USAe Groupe d’analyse, Ltée, Montréal, QC, Canadaf MSD (UK) Limited, London, UK
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-02T08:07:37Z
      DOI: 10.1080/10428194.2024.2331631
       
  • BRAF mutation in myeloid neoplasm: incidences and clinical outcomes

    • Free pre-print version: Loading...

      Authors: Tareq AbuasabShehab MohamedNaveen PemmarajuTapan M. KadiaNaval DaverCourtney D. DiNardoFarhad RavandiWei QiaoGuillermo Montalban-BravoGautam Borthakura Department of Leukemia; The University of Texas MD Anderson Cancer Center, Houston, TX, USAb Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
      Pages: 1 - 6
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-05-02T08:06:47Z
      DOI: 10.1080/10428194.2024.2347539
       
  • Direct and indirect costs for patients with myeloproliferative neoplasms

    • Free pre-print version: Loading...

      Authors: Jingbo YuJames NelsonTaylor MarlinEvan BraunsteinMichelle Jerrya Incyte Corporation; Wilmington, DE, USAb Merative, Ann Arbor, MI, USA
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-27T08:35:00Z
      DOI: 10.1080/10428194.2024.2338849
       
  • Targets and treatments in primary CNS lymphoma

    • Free pre-print version: Loading...

      Authors: Christina von RoemelingAndrés J. M. FerreriCarole SoussainHan W. TunChristian Grommesa Preston A. Wells Center for Brain Tumor Therapy; Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USAb Department of Onco-Hematology, University Vita-Salute San Raffaele, Milano, Italyc Department of Onco-Hematology, Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milano, Italyd Institut Curie, Service d’Hématologie, site de Saint-Cloud, Francee INSERM U932, Institut Curie, PSL Research University, Paris, Francef Department of Hematology, Mayo Clinic, Jacksonville, Florida, USAg Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USAh Department of Neurology, Weill Cornell Medical College, New York, New York, USA
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-25T05:41:49Z
      DOI: 10.1080/10428194.2024.2342560
       
  • Effect of tyrosine kinase inhibitors on male fertility in patients with
           chronic phase chronic myeloid leukemia

    • Free pre-print version: Loading...

      Authors: George NesrSimone ClaudianiDragana MilojkovicAndrew InnesFiona FernandoIrene CaballesPatience MungoziRichard SzydloSilvia LovatoChanna JayasenaJane Apperleya Centre for Haematology; Imperial College London, London, UKb Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UKc Section of Investigation Medicine, Imperial College London, Faculty of Medicine, London, UKd Department of Andrology, North-West London Pathology, Hammersmith Hospital, London, UK
      Pages: 1 - 6
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-23T07:35:37Z
      DOI: 10.1080/10428194.2024.2343758
       
  • Challenges in management of older patients with chronic myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Jessica M. StempelRory M. ShallisRong WongNikolai A. Podoltseva Section of Hematology; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAb Cancer Outcomes, Public Policy, Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USAc Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA
      Pages: 1 - 14
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-23T07:29:58Z
      DOI: 10.1080/10428194.2024.2342559
       
  • Evaluating targeted therapies in older patients with TP53-mutated AML

    • Free pre-print version: Loading...

      Authors: Jean M.G. SabileRonan SwordsJeffrey W. Tynera Knight Cancer Institute; Oregon Health & Science University, Portland, OR, USAb Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USAc Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA
      Pages: 1 - 18
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-22T09:09:24Z
      DOI: 10.1080/10428194.2024.2344057
       
  • Evaluation of safety outcomes with transitioning obinutuzumab from
           standard rate to short duration infusion in patients with chronic
           lymphocytic leukemia

    • Free pre-print version: Loading...

      Authors: Caroline FleckAllison KarabinosAllene CookDonald C. MooreRyan Jacobsa Department of Pharmacy; Levine Cancer Institute, Atrium Health, Charlotte, NC, USAb Department of Hematologic Oncology Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
      Pages: 1 - 2
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-22T09:08:45Z
      DOI: 10.1080/10428194.2024.2341999
       
  • Cost-effectiveness of adding quizartinib to induction chemotherapy for
           patients with FLT3-mutant acute myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Jan Philipp BewersdorfKishan K. PatelRory M. ShallisNikolai A. PodoltsevTariq KewanJessica StempelLourdes MendezMaximilian StahlEytan M. SteinScott F. HuntingtonGeorge GoshuaAmer M. Zeidana Leukemia Service; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NYb Department of Medicine, Brigham Evaluation, Yale New Haven Hospital, New Haven, CT
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-22T07:44:00Z
      DOI: 10.1080/10428194.2024.2344052
       
  • A retrospective cohort study describing chemotherapy-induced peripheral
           neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R:
           does HIV status matter'

    • Free pre-print version: Loading...

      Authors: Gretchen A. McNallyConnor M. AosseyTracy WiczerLoraine T. SinnottMark LustbergRobert A. BaiocchiMaryam Lustberga The Ohio State University Comprehensive Cancer Center; Columbus, OH, USAb Data Coordination Analysis Center, College of Optometry, The Ohio State University, Columbus, OH, USAc Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAd Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USAe Yale Cancer Center, New Haven, CT, USA
      Pages: 1 - 7
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-22T07:41:52Z
      DOI: 10.1080/10428194.2024.2340051
       
  • Light-chain-restricted Russell body oral mucositis: an immunohistochemical
           study and literature review

    • Free pre-print version: Loading...

      Authors: Luana Stefanie Silvino GonçalvesKarina Helen MartinsMagdalena Raquel Torres ReyesIsabella Silva CatanantiFernando ChahudJorge Esquiche Leóna Department of Pediatric Dentistry - Riberão Preto Dental School (FORP/USP); University of São Paulo, Ribeirão Preto, São Paulo, Brazilb Department of Pathology Forensic Medicine, Ribeirão Preto Medical School (FMRP/USP), University of São Paulo, Avenida do Café, Ribeirão Preto, São Paulo, Brazil
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-19T06:41:22Z
      DOI: 10.1080/10428194.2024.2342564
       
  • Management of relapsed/refractory mantle cell lymphoma

    • Free pre-print version: Loading...

      Authors: Musa AlzahraniDiego Villaa Department of Medicine; College of Medicine, King Saud University, Riyadh, Saudi Arabiab Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canadac Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-18T05:16:30Z
      DOI: 10.1080/10428194.2024.2338851
       
  • High remission rates and transition to allogeneic transplant in older
           patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia
           with midostaurin plus intensive chemotherapy

    • Free pre-print version: Loading...

      Authors: Jose TinajeroDat NgoJianying ZhangNi-Chun TsaiAhmed AribiIbrahim AldossVaibhav AgrawalShukaib ArslanIdoroenyi AmanamHoda PourhassanKaramjeet SandhuMonzr Al-MalkiVinod PullarkatPamela BeckerRyotaro NakamuraAnthony SteinGuido MarcucciAndrew ArtzPaul KollerAmandeep Salhotraa Department of Pharmacy; City of Hope Medical Center, Duarte, CA, USAb Department of Hematology Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USAc Division of Biostatistics, City of Hope Medical Center, Duarte, CA, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-18T04:27:17Z
      DOI: 10.1080/10428194.2024.2332506
       
  • Flotetuzumab as a salvage immunotherapy in advanced CD123-positive
           hematological malignancies, a phase 1 pilot study

    • Free pre-print version: Loading...

      Authors: Ibrahim AldossJianying ZhangMarjorie RobbinsJoo SongMonzr M. Al MalkiSalman OtoukeshKaramjeet SandhuVaibhav AgrawalAlex F. HerreraLeslie L. PopplewellLucy GhodaAnthony SteinGuido MarcucciStephen FormanVinod Pullarkata Department of Hematology; Hematopoietic Cell Transplantation, City of Hope National Medical center, Duarte, California, USA
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-17T08:22:07Z
      DOI: 10.1080/10428194.2024.2343029
       
  • COVID-19 antibody titers after tixagevimab–cilgavimab injection in
           patients with hematologic diseases; a single-center, prospective study

    • Free pre-print version: Loading...

      Authors: Naokazu NakamuraHiroko TsunemineRyo IkunariTomomi SakaiNobuyoshi Arimaa Department of Hematology; Shinko Hospital, Kobe, Japanb Department of Hematology Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japanc Department of Hematology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-16T08:59:38Z
      DOI: 10.1080/10428194.2024.2343519
       
  • Prevalence of geriatric impairments and frailty categorization among
           real-world patients with multiple myeloma: a prospective cohort study
           (MFRAIL)

    • Free pre-print version: Loading...

      Authors: Imran HaiderDarryl P. LeongMartha LouzadaArleigh McCurdyGregory R. PondRuthanne CameronMohammed AljamaAlissa VisramTanya M. WildesHira Miana Royal College of Surgeons in Ireland; Dublin, Irelandb Department of Medicine Population Health Research Institute, McMaster University, Hamilton, Canadac Department of Medicine, University of Western Ontario, London, Canadad The Ottawa Hospital Research Institute, Ottawa, Canadae Department of Oncology, McMaster University, Hamilton, Canadaf Department of Medicine, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE, USA
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-16T02:08:34Z
      DOI: 10.1080/10428194.2024.2340052
       
  • B cell receptor signaling proteins as biomarkers for progression of CLL
           requiring first-line therapy

    • Free pre-print version: Loading...

      Authors: Mischa Y. L. VervoordeldonkPaul J. HengeveldMark-David LevinAnton W. Langeraka Department of Immunology; Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlandsb Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-15T02:25:08Z
      DOI: 10.1080/10428194.2024.2341151
       
  • The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes
           within the veterans health administration (VHA)

    • Free pre-print version: Loading...

      Authors: Andrew TaSupreet KaurMichael MaderKathleen FranklinMadison WilliamsRyan WilliamsJean-Pierre BlaizeAmna NaqviSnegha AnanthMichael SongBrian Oliver WarneckeAbhishek PandyaLakene Raissa Djoufack DjoumessiPhillip NazarewiczManuel Espinoza-GutarraKana Tai LuceroJennifer WhiteheadAlaq Al-AbayechiLauren BoyleSophia LeeGabriel Roman SouzaEsteban Toro VelezIan MinesZohra Nooruddina University of Texas Health Science Center at San Antonio; San Antonio, TX, USAb South Texas Veterans Health Care System, San Antonio, TX, USAc University of Texas MD Anderson Cancer Center, Houston, TX, USAd Department of Oncology, Augusta University, Augusta, GA, USAe Baylor College of Medicine, Houston, TX, USAf O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USAg Department of Hematology Medical Oncology, Moffitt Cancer Center, Tampa, FL, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-15T02:23:28Z
      DOI: 10.1080/10428194.2024.2338856
       
  • Two recurrent types of IGH::5′ BCL2 breakpoints representing cytogenetic
           ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the VDJ and
           class switch recombination processes, respectively

    • Free pre-print version: Loading...

      Authors: Fumiyo MaekawaMasahiko HayashidaKayo TakeokaKatsuhiro FukutsukaMiho NakagawaTakashi AkasakaShinichi SakamotoShinji SumiyoshiYoichiro KobashiHitoshi Ohnoa Tenri Institute of Medical Research; Tenri Hospital, Tenri, Nara, Japanb Department of Hematology, Tenri Hospital, Tenri, Nara, Japanc Department of Diagnostic Pathology, Tenri Hospital, Tenri, Nara, Japan
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-12T08:28:14Z
      DOI: 10.1080/10428194.2024.2341333
       
  • Successful treatment with cladribine in a patient with Rosai–Dorfman
           disease complicated by severe, prolonged marrow aplasia

    • Free pre-print version: Loading...

      Authors: Tadeusz RobakMarcin BraunAnna GuminskaElżbieta Iskierka-JażdżewskaPaweł Robaka Department of Hematology; Medical University of Lodz, Lodz, Polandb Department of General Hematology, Copernicus Memorial Hospital, Lodz, Polandc Department of Pathology, Medical University of Lodz, Lodz, Polandd Department of Nuclear Medicine, Copernicus Memorial Hospital, Lodz, Polande Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Poland
      Pages: 1 - 6
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-12T08:26:04Z
      DOI: 10.1080/10428194.2024.2340058
       
  • The mechanism of action, pharmacological characteristics, and clinical
           utility of the amyloid depleter birtamimab for the potential treatment of
           AL amyloidosis

    • Free pre-print version: Loading...

      Authors: Giovanni PalladiniMichaela LiedtkeWagner ZagoPhil DolanGene G. KinneyMorie A. Gertza Department of Molecular Medicine; University of Pavia, Pavia, Italyb Amyloidosis Research Treatment Center, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italyc Stanford Cancer Institute, Stanford, CA, USAd Prothena Biosciences Inc, Brisbane, CA, USAe Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-11T07:45:08Z
      DOI: 10.1080/10428194.2024.2337803
       
  • Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary
           central nervous system lymphoma (PCNSL): current progress and latest
           advances

    • Free pre-print version: Loading...

      Authors: Lauren SchaffLakshmi NayakChristian Grommesa Department of Neurology; Memorial Sloan Kettering Cancer Center, New York, NY, USAb Department of Neurology, Weill Cornell Medical Center, New York, NY, USAc Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-10T10:01:34Z
      DOI: 10.1080/10428194.2024.2333985
       
  • Safety and efficacy of parsaclisib in combination with rituximab,
           bendamustine + rituximab, or ibrutinib in patients with previously
           treated B-cell lymphoma: analysis of a phase 1 dose-finding study
           (CITADEL‑112)

    • Free pre-print version: Loading...

      Authors: Juan-Manuel SanchoPau AbrisquetaAbhijeet KumarRaul CordobaMonica TaniPeter LangmuirErica RappoldTeng LiuArmando Lopez-Guillermoa Clinical Hematology Department; IJC, Hospital Germans Trias i Pujol, Institut Català d‘Oncologia, Barcelona, Spainb Department of Hematology, Vall d‘Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d‘Hebron, Barcelona, Spainc University of Arizona, Tucson, AZ, USAd Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spaine Haematology Unit Santa Maria delle Croci Hospital, Ravenna, Italyf Incyte Corporation, Wilmington, DE, USAg Clinic Barcelona, Barcelona, Spain
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-10T05:38:25Z
      DOI: 10.1080/10428194.2024.2331626
       
  • The prognostic significance of genomic complexity in patients with CLL

    • Free pre-print version: Loading...

      Authors: Ellinor GoergenOthman Al-SawafFaculty of Medicine; University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany
      Pages: 1 - 9
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-09T05:20:54Z
      DOI: 10.1080/10428194.2024.2333448
       
  • Normal and malignant cells are homogeneously distributed in the bone
           marrow of children

    • Free pre-print version: Loading...

      Authors: Sharon VeenbergenRomana JugooaJeroen te MarveldeAndrica C.H de VriesVincent H. J. van der Veldena Laboratory Medical Immunology; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlandsb Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-08T10:31:24Z
      DOI: 10.1080/10428194.2024.2337782
       
  • Gammopathic dermopathy: characterization of cutaneous MGUS

    • Free pre-print version: Loading...

      Authors: Emily R. GordonCaroline ChenMegan H. TragerOluwaseyi AdeuyanBrigit A. LapollaLauren M. FahmyCeline M. SchreidahDavid A. WetterLarisa J. Geskina Columbia University Vagelos College of Physicians; Surgeons, New York, NY, USAb Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USAc Department of Dermatology, Mayo Clinic, Rochester, MN, USA
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-06T01:09:53Z
      DOI: 10.1080/10428194.2024.2336046
       
  • Hospital healthcare resource utilization and costs for chimeric antigen
           T-cell therapy and autologous hematopoietic cell transplant in patients
           with large B-cell lymphoma in the United States

    • Free pre-print version: Loading...

      Authors: Chendi CuiChaoling FengNing RosenthalSally W. WadeLaura CurryChristine FuGunjan L. Shaha PINC AI Applied Sciences; Premier Inc, Charlotte, NC, USAb Kite Pharma Inc, Santa Monica, CA, USAc Wade Outcomes Research Consulting, Salt Lake City, UT, USAd Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
      Pages: 1 - 10
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-03T09:34:25Z
      DOI: 10.1080/10428194.2024.2331084
       
  • Successful treatment with bortezomib, thalidomide and dexamethasone in
           plasma cell myeloma post-bone marrow transplant

    • Free pre-print version: Loading...

      Authors: Yaqing CaoJingjing ShangYingying ZhaiQingyuan WangLingzhi YanXiaolan ShiJing WangYing YaoHuifen ZhouAining SunMiao MiaoChengcheng FuSong Jina National Clinical Research Centre for Haematologic Diseases; Jiangsu Institute of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, Chinab Institute of Blood Haemostasis of Ministry of Health, Suzhou, China
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-04-01T02:43:56Z
      DOI: 10.1080/10428194.2024.2329322
       
  • Olutasidenib in post-venetoclax patients with mutant isocitrate
           dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)

    • Free pre-print version: Loading...

      Authors: Jorge CortesBrian A. JonasGary SchillerAlice MimsGail J. RobozAndrew H. WeiPau MontesinosP. Brent FerrellKaren WL. YeePierre FenauxAnthony SchwarerJustin M. Wattsa Department of Medicine; Georgia Cancer Center, Augusta University, Augusta, GA, USAb Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USAc Department of Internal Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USAd Division of Hematology, The Ohio State University, Columbus, OH, USAe Department of Hematology Eastern Health Clinical School, Melbourne, Australial Division of Hematology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-28T04:03:26Z
      DOI: 10.1080/10428194.2024.2333451
       
  • Immunohistochemistry-based detection of TP53 mutations in acute myeloid
           leukemia: a promising high sensitivity diagnostic approach

    • Free pre-print version: Loading...

      Authors: Andrew MatthewsElena FenuSarah J. SkuliJaryse C. HarrisCatherine Laia Hematology Oncology; University of Pennsylvania, Philadelphia, PA, USAb Pathology, Virginia Commonwealth University Medical Center, Richmond, VA, USAc Pathology Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-27T01:32:32Z
      DOI: 10.1080/10428194.2024.2332505
       
  • Significant impact of antibiotic exposure on GI-GVHD, NRM, and GRFS
           following allogeneic HCT with non-myeloablative Flu-TBI conditioning

    • Free pre-print version: Loading...

      Authors: Lenneke F. J. van GroningenSuzanne van DorpManita E. J. BremmersShahira FazelMieke W. H. RoevenNicole M. A. BlijlevensWalter J. F. M. van der Veldena Department of Hematology; Radboud University Medical Center, Nijmegen, The Netherlandsb Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
      Pages: 1 - 8
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-23T07:03:22Z
      DOI: 10.1080/10428194.2024.2331081
       
  • Progressive TP53 inactivation in an aggressive splenic diffuse red pulp
           small B-cell lymphoma

    • Free pre-print version: Loading...

      Authors: Maria-Myrsini TzioniAlexandra ClipsonZi ChenFrancesco CuccoAndrew WotherspoonStefan DojcinovMing-Qing Dua Division of Cellular; Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UKb Histopathology Department, The Royal Marsden Hospital, London, UKc Department of Pathology, Morriston Hospital, Swansea Bay University Health Board/Swansea University, Swansea, UK
      Pages: 1 - 5
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-22T10:00:43Z
      DOI: 10.1080/10428194.2024.2332508
       
  • Predictive value of early molecular response to tyrosine kinase inhibitors
           in pediatric patients with chronic myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Aya M. AbdallahHanafy HafezYoussef MadneySonia AhmedDina YassinSherine SalemRodina YousryHisham Abdel-AzimLeslie LehmannAlaa Elhaddada Department of Pediatric Oncology; Children’s Cancer Hospital Egypt (CCHE 57357), Cairo, Egyptb Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egyptc Department of Clinical Pathology, Children’s Cancer Hospital Egypt (CCHE 57357), Cairo, Egyptd Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypte Department of Research, Children’s Cancer Hospital (CCHE 57357), Cairo, Egyptf Cancer Center, Children Hospital Medical Center, Loma Linda University, Loma Linda, CA, USAg Pediatric Stem Cell Transplantation Unit, Dana Farber Cancer Institute, Boston, MA, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-21T07:23:41Z
      DOI: 10.1080/10428194.2024.2331625
       
  • RAD21 mutations in acute myeloid leukemia

    • Free pre-print version: Loading...

      Authors: Dorottya LaczkoCorey Poveda-RogersAndrew H. MatthewsOraine SnaithSelina LugerAdam BaggGabriel C. CaponettiJennifer J.D MorrissetteGuang Yanga Department of Pathology; Laboratory Medicine, Hospital of the University of Pennsylvania and, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
      Pages: 1 - 7
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-20T09:50:45Z
      DOI: 10.1080/10428194.2024.2328233
       
  • Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline
           hemoglobin levels in the SIMPLIFY-1 trial

    • Free pre-print version: Loading...

      Authors: Vikas GuptaStephen OhTimothy DevosViviane DubruilleJohn CatalanoTim C. P. SomervailleUwe PlatzbeckerPilar GiraldoHiroshi KosugiTomasz SachaJiri MayerArpad IllesCatherine EllisZhaohui WangFrancisco J. Gonzalez CarrerasBryan StrouseRuben Mesaa Princess Margaret Cancer Centre; Toronto, Canadab Washington University School of Medicine, St. Louis, MO, USAc Department of Hematology, University Hospitals Leuven, Leuven, Belgiumd Department of Microbiology Hemostaseology, University of Leipzig, Leipzig, Germanyi Department of Hematology, Hospital Quironsalud, Zaragoza, Spainj Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japank Jagiellonian University Hospital, Kraków, Polandl University Hospital Brno, Brno, Czech Republicm Department of Internal Medicine, Division of Haematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungaryn GSK plc, Philadelphia, PA, USAo GSK plc, Stevenage, UKp Wake Forest University School of Medicine, Winston-Salem, NC, USA
      Pages: 1 - 13
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-19T12:51:32Z
      DOI: 10.1080/10428194.2024.2328800
       
  • Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same
           patient: a case series and literature review

    • Free pre-print version: Loading...

      Authors: Gilad ItchakiOsnat JarhovskyJorge J. CastilloHamza HassanMoshe L. GattMerav LeibaPia RaananiMorie A. GertzIuliana Vaxmana Sackler Faculty of Medicine; Tel-Aviv University, Tel-Aviv, Israelb Hematology, Meir Medical Center, Kfar-Saba, Israelc Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USAd Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israele Assuta Ashdod University Hospital, Faculty of Health Science, Ben-Gurion University of the Negev, Negev, Israelf Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikvah, Israelg Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA
      Pages: 1 - 7
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-19T12:51:14Z
      DOI: 10.1080/10428194.2024.2332499
       
  • Chidamide enhances T-cell-mediated anti-tumor immune function by
           inhibiting NOTCH1/NFATC1 signaling pathway in ABC-type diffuse large
           B-cell lymphoma

    • Free pre-print version: Loading...

      Authors: Li LiWenjing YangYuanyuan PanRuyu YeYu WangSijia LiHaoyan JiangQi ZhangXiaobo WangJinsong YanDepartment of Hematology; The Second Hospital of Dalian Medical University, Dalian, People’s Republic of China
      Pages: 1 - 16
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-18T11:47:22Z
      DOI: 10.1080/10428194.2024.2328227
       
  • Corynebacterium bacteremia in patients with hematologic disorders: a case
           series and systematic literature review

    • Free pre-print version: Loading...

      Authors: Tomohito ShimadaKazuhiro IshikawaFujimi KawaiNobuyoshi Moria Department of Infectious Diseases; St. Luke’s International Hospital, Tokyo, Japanb Library, Department of Academic Resources, St. Luke’s International University, Tokyo, Japan
      Pages: 1 - 6
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-18T07:18:23Z
      DOI: 10.1080/10428194.2024.2331086
       
  • Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells via
           modulation of NF-κB, AP-1, and Akt signaling

    • Free pre-print version: Loading...

      Authors: Chie IshikawaNaoki Moria Department of Microbiology; Island Studies, University of the Ryukyus, Nishihara, Okinawa, Japan
      Pages: 1 - 11
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-15T08:35:20Z
      DOI: 10.1080/10428194.2024.2328219
       
  • Flow cytometry is a sensitive technique to assess marrow involvement by B
           cell non-Hodgkins lymphoma

    • Free pre-print version: Loading...

      Authors: Thulasi Raman RamalingamDepartment of Hematology; Apollo Cancer centres, Chennai, India
      Pages: 1 - 2
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-15T06:29:09Z
      DOI: 10.1080/10428194.2024.2330707
       
  • A phase 1 study of interleukin-15 in combination with avelumab in relapsed
           or refractory T-cell lymphoma

    • Free pre-print version: Loading...

      Authors: Max J. GordonSigrid DuboisBonita BryantSamuel NgKevin ConlonMilos D. MiljkovicThomas WaldmannMark Roschewskia Lymphoid Malignancies Branch; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USAb Cartesian therapeutics, Gaithersburg, MD, USA
      Pages: 1 - 4
      Abstract: .

      Citation: Leukemia & Lymphoma
      PubDate: 2024-03-09T08:08:55Z
      DOI: 10.1080/10428194.2024.2326847
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 44.213.60.33
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-
JournalTOCs
 
 
  Subjects -> MEDICAL SCIENCES (Total: 8186 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (205 journals)
    - ANAESTHESIOLOGY (105 journals)
    - CARDIOVASCULAR DISEASES (334 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (19 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (227 journals)
    - DENTISTRY (266 journals)
    - DERMATOLOGY AND VENEREOLOGY (162 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (121 journals)
    - ENDOCRINOLOGY (149 journals)
    - FORENSIC SCIENCES (43 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (178 journals)
    - GERONTOLOGY AND GERIATRICS (125 journals)
    - HEMATOLOGY (160 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (178 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (90 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2230 journals)
    - NURSES AND NURSING (331 journals)
    - OBSTETRICS AND GYNECOLOGY (199 journals)
    - ONCOLOGY (355 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (135 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (150 journals)
    - OTORHINOLARYNGOLOGY (76 journals)
    - PATHOLOGY (96 journals)
    - PEDIATRICS (254 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (153 journals)
    - PSYCHIATRY AND NEUROLOGY (800 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (182 journals)
    - RESPIRATORY DISEASES (109 journals)
    - RHEUMATOLOGY (76 journals)
    - SPORTS MEDICINE (77 journals)
    - SURGERY (388 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (151 journals)

HEMATOLOGY (160 journals)                     

Showing 1 - 122 of 122 Journals sorted alphabetically
Acta Angiologica     Open Access   (Followers: 3)
Adipocyte     Open Access  
Advances in Hematology     Open Access   (Followers: 13)
Africa Sanguine     Full-text available via subscription  
American Journal of Hematology     Hybrid Journal   (Followers: 46)
Anemia     Open Access   (Followers: 6)
Annals of Hematology     Hybrid Journal   (Followers: 14)
Arteriosclerosis, Thrombosis and Vascular Biology     Full-text available via subscription   (Followers: 25)
Artery Research     Hybrid Journal   (Followers: 4)
Artificial Cells, Nanomedicine and Biotechnology     Hybrid Journal   (Followers: 3)
ASAIO Journal     Hybrid Journal   (Followers: 2)
Best Practice & Research Clinical Haematology     Hybrid Journal   (Followers: 5)
Blood     Hybrid Journal   (Followers: 296)
Blood Advances     Open Access   (Followers: 9)
Blood and Lymphatic Cancer : Targets and Therapy     Open Access   (Followers: 7)
Blood Cancer Journal     Open Access   (Followers: 21)
Blood Cells, Molecules, and Diseases     Hybrid Journal   (Followers: 5)
Blood Coagulation & Fibrinolysis     Hybrid Journal   (Followers: 27)
Blood Pressure     Open Access   (Followers: 1)
Blood Pressure Monitoring     Hybrid Journal   (Followers: 2)
Blood Reviews     Hybrid Journal   (Followers: 20)
BMJ Open Diabetes Research & Care     Open Access   (Followers: 23)
Bone Marrow Transplantation     Hybrid Journal   (Followers: 15)
British Journal of Haematology     Hybrid Journal   (Followers: 54)
Canadian Journal of Diabetes     Hybrid Journal   (Followers: 9)
Case Reports in Hematology     Open Access   (Followers: 10)
Clinical and Applied Thrombosis/Hemostasis     Open Access   (Followers: 28)
Clinical Diabetes     Full-text available via subscription   (Followers: 30)
Clinical Diabetes and Endocrinology     Open Access   (Followers: 14)
Clinical Lymphoma & Myeloma     Full-text available via subscription   (Followers: 2)
Conquest : The Official Journal of Diabetes Australia     Full-text available via subscription   (Followers: 1)
Current Angiogenesis     Hybrid Journal   (Followers: 1)
Current Diabetes Reports     Hybrid Journal   (Followers: 14)
Current Diabetes Reviews     Hybrid Journal   (Followers: 13)
Current Hematologic Malignancy Reports     Hybrid Journal   (Followers: 2)
Current Opinion in Hematology     Hybrid Journal   (Followers: 14)
Cytotherapy     Full-text available via subscription   (Followers: 1)
Der Diabetologe     Hybrid Journal  
Diabetes     Full-text available via subscription   (Followers: 262)
Diabetes aktuell     Hybrid Journal   (Followers: 2)
Diabetes and Vascular Disease Research     Hybrid Journal   (Followers: 8)
Diabetes Care     Full-text available via subscription   (Followers: 285)
Diabetes Case Reports     Open Access  
Diabetes Educator     Hybrid Journal   (Followers: 10)
Diabetes Research and Clinical Practice     Hybrid Journal   (Followers: 18)
Diabetes Spectrum     Full-text available via subscription   (Followers: 14)
Diabetes Technology & Therapeutics     Hybrid Journal   (Followers: 8)
Diabetes Therapy     Open Access   (Followers: 13)
Diabetic Foot & Ankle     Open Access   (Followers: 9)
Diabetic Medicine     Hybrid Journal   (Followers: 93)
Diabetologia     Hybrid Journal   (Followers: 107)
Diabetologie und Stoffwechsel     Hybrid Journal  
Egyptian Journal of Hematology and Bone Marrow Transplantation     Open Access   (Followers: 9)
eJHaem     Open Access   (Followers: 1)
European Journal of Haematology     Hybrid Journal   (Followers: 12)
Experimental Hematology     Hybrid Journal   (Followers: 3)
Experimental Hematology & Oncology     Open Access   (Followers: 6)
Expert Review of Hematology     Hybrid Journal   (Followers: 4)
Fluids and Barriers of the CNS     Open Access   (Followers: 1)
Haematologica - the Hematology journal     Open Access   (Followers: 35)
Haemophilia     Hybrid Journal   (Followers: 15)
Hematologia     Full-text available via subscription   (Followers: 3)
Hematology     Open Access   (Followers: 9)
Hematology, Transfusion and Cell Therapy     Open Access   (Followers: 2)
Hemodialysis International     Hybrid Journal   (Followers: 3)
Hepatitis Monthly     Open Access   (Followers: 3)
Immunohematology : Journal of Blood Group Serology and Molecular Genetics     Hybrid Journal   (Followers: 3)
Indian Journal of Hematology and Blood Transfusion     Hybrid Journal   (Followers: 1)
Info Diabetologie     Full-text available via subscription  
InFo Hämatologie + Onkologie : Interdisziplinäre Fortbildung von Ärzten für Ärzte     Full-text available via subscription  
Integrated Blood Pressure Control     Open Access   (Followers: 1)
International Blood Research & Reviews     Open Access  
International Journal of Clinical Transfusion Medicine     Open Access   (Followers: 3)
International Journal of Diabetes in Developing Countries     Hybrid Journal   (Followers: 5)
International Journal of Diabetes Research     Open Access   (Followers: 6)
International Journal of Hematology     Hybrid Journal   (Followers: 3)
International Journal of Hematology Research     Open Access   (Followers: 2)
International Journal of Laboratory Hematology     Hybrid Journal   (Followers: 24)
JMIR Diabetes     Open Access  
Journal of Blood Medicine     Open Access  
Journal of Cerebral Blood Flow & Metabolism     Hybrid Journal   (Followers: 3)
Journal of Diabetes     Open Access   (Followers: 12)
Journal of Diabetes and its Complications     Hybrid Journal   (Followers: 13)
Journal of Diabetes and Metabolic Disorders     Open Access   (Followers: 6)
Journal of Diabetes Investigation     Open Access   (Followers: 6)
Journal of Diabetes Mellitus     Open Access   (Followers: 4)
Journal of Hematological Malignancies     Open Access  
Journal of Hematology and Transfusion Medicine     Open Access   (Followers: 1)
Journal of Hematopathology     Hybrid Journal   (Followers: 3)
Journal of Pediatric Hematology/Oncology     Hybrid Journal   (Followers: 6)
Journal of Social Health and Diabetes     Open Access  
Journal of Thrombosis and Haemostasis     Hybrid Journal   (Followers: 52)
Journal of Thrombosis and Thrombolysis     Hybrid Journal   (Followers: 30)
Leukemia     Hybrid Journal   (Followers: 23)
Leukemia and Lymphoma     Hybrid Journal   (Followers: 13)
Leukemia Research     Hybrid Journal   (Followers: 9)
Leukemia Research Reports     Open Access   (Followers: 1)
Leukemia Supplements     Full-text available via subscription  
Nederlands Tijdschrift voor Diabetologie     Hybrid Journal  
Nutrition & Diabetes     Open Access   (Followers: 18)
Oncohematology     Open Access   (Followers: 1)
Open Diabetes Journal     Open Access  
Open Hematology Journal     Open Access   (Followers: 1)
Open Hypertension Journal     Open Access  
Open Journal of Blood Diseases     Open Access  
Pediatric Blood & Cancer     Hybrid Journal   (Followers: 6)
Pediatric Hematology Oncology Journal     Open Access   (Followers: 3)
Peritoneal Dialysis International     Hybrid Journal  
Plasmatology     Open Access   (Followers: 1)
Platelets     Hybrid Journal   (Followers: 2)
Practical Diabetes     Hybrid Journal   (Followers: 4)
Primary Care Diabetes     Hybrid Journal   (Followers: 16)
Research and Practice in Thrombosis and Haemostasis     Open Access   (Followers: 2)
Revista Cubana de Hematología, Inmunología y Hemoterapia     Open Access  
Seminars in Hematology     Hybrid Journal   (Followers: 9)
Seminars in Thrombosis and Hemostasis     Hybrid Journal   (Followers: 28)
The Lancet Haematology     Full-text available via subscription   (Followers: 43)
Therapeutic Advances in Hematology     Hybrid Journal  
Thrombosis & Haemostasis     Hybrid Journal   (Followers: 105)
Thrombosis Research     Hybrid Journal   (Followers: 30)
Transplantation and Cellular Therapy     Hybrid Journal   (Followers: 11)
Veins and Lymphatics     Open Access   (Followers: 1)

           

Similar Journals
Similar Journals
HOME > Browse the 73 Subjects covered by JournalTOCs  
SubjectTotal Journals
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 44.213.60.33
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-